• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型噻唑烷-2,4-二酮衍生物的正常血糖及生物活性

Euglycaemic and biological activities of novel thiazolidine-2,4-dione derivatives.

作者信息

de Nanteuil G, Herve Y, Duhault J, Espinal J, Boulanger M, Ravel D

机构信息

Division of Medicinal Chemistry, Institut de Recherches Servier, Suresnes, France.

出版信息

Arzneimittelforschung. 1995 Nov;45(11):1176-81.

PMID:8929235
Abstract

A new series of thiazolidine-2,4-dione derivatives was obtained by incorporating one or the other of the two carbons of the central chain into different rings. These compounds lower blood glucose levels in the genetically obese and insulin-resistant ob/ob mouse. Moreover, they decreased insulin and triglyceride levels in the Zucker fa/fa rat. Incorporation of the left hand carbon of the chain afforded compounds among which pyrrolidino derivatives 5, 9 and 13 were the most potent. The same carbon atom was used to elaborate different types of rings (benzocyclobutane, benzodioxane), giving rise to compounds 14 and 19 with moderate to good activity. Finally, cyclization using the right hand carbon of the chain gave rise to highly potent benzofurane 24.

摘要

通过将中心链的两个碳原子中的一个或另一个并入不同的环中,得到了一系列新的噻唑烷-2,4-二酮衍生物。这些化合物可降低遗传性肥胖且胰岛素抵抗的ob/ob小鼠的血糖水平。此外,它们还降低了Zucker fa/fa大鼠的胰岛素和甘油三酯水平。将链的左手碳原子并入得到的化合物中,吡咯烷基衍生物5、9和13活性最强。同一个碳原子用于构建不同类型的环(苯并环丁烷、苯并二恶烷),得到了活性中等至良好的化合物14和19。最后,使用链的右手碳原子进行环化得到了活性很强的苯并呋喃24。

相似文献

1
Euglycaemic and biological activities of novel thiazolidine-2,4-dione derivatives.新型噻唑烷-2,4-二酮衍生物的正常血糖及生物活性
Arzneimittelforschung. 1995 Nov;45(11):1176-81.
2
Novel 5-(3-aryl-2-propynyl)-5-(arylsulfonyl)thiazolidine-2,4-diones as antihyperglycemic agents.
J Med Chem. 1998 Mar 26;41(7):1084-91. doi: 10.1021/jm9706168.
3
Improved metabolic status and insulin sensitivity in obese fatty (fa/fa) Zucker rats and Zucker Diabetic Fatty (ZDF) rats treated with the thiazolidinedione, MCC-555.噻唑烷二酮类药物MCC - 555治疗肥胖型脂肪(fa/fa) Zucker大鼠和Zucker糖尿病脂肪(ZDF)大鼠可改善其代谢状态和胰岛素敏感性。
Br J Pharmacol. 1998 Dec;125(8):1708-14. doi: 10.1038/sj.bjp.0702245.
4
Novel antidiabetic and hypolipidemic agents. 3. Benzofuran-containing thiazolidinediones.新型抗糖尿病和降血脂药物。3. 含苯并呋喃的噻唑烷二酮类化合物。
J Med Chem. 1999 Jun 3;42(11):1927-40. doi: 10.1021/jm980549x.
5
Discovery of imidazo[1,2-b]thiazole derivatives as novel SIRT1 activators.发现咪唑并[1,2-b]噻唑衍生物作为新型 SIRT1 激活剂。
J Med Chem. 2009 Mar 12;52(5):1275-83. doi: 10.1021/jm8012954.
6
Novel euglycemic and hypolipidemic agents. 1.新型正常血糖和降血脂药物。1.
J Med Chem. 1998 May 7;41(10):1619-30. doi: 10.1021/jm970444e.
7
Novel euglycemic and hypolipidemic agents. 4. Pyridyl- and quinolinyl-containing thiazolidinediones.新型正常血糖和降血脂药物。4. 含吡啶基和喹啉基的噻唑烷二酮类化合物。
J Med Chem. 1999 Jul 15;42(14):2569-81. doi: 10.1021/jm980622j.
8
Novel thiazolidine-2,4-diones as potent euglycemic agents.
J Med Chem. 1992 May 15;35(10):1853-64. doi: 10.1021/jm00088a022.
9
Insulin resistance in the Zucker diabetic fatty rat: a metabolic characterisation of obese and lean phenotypes.Zucker糖尿病脂肪大鼠的胰岛素抵抗:肥胖和瘦型表型的代谢特征
Acta Diabetol. 2005 Dec;42(4):162-70. doi: 10.1007/s00592-005-0197-8.
10
Pharmacological characteristics of a novel nonthiazolidinedione insulin sensitizer, FK614.新型非噻唑烷二酮类胰岛素增敏剂FK614的药理学特性
Eur J Pharmacol. 2004 Jun 28;494(2-3):273-81. doi: 10.1016/j.ejphar.2004.04.038.

引用本文的文献

1
Molecular Characterization of Constipation Disease as Novel Phenotypes in CRISPR-Cas9-Generated Leptin Knockout Mice with Obesity.肥胖症 CRISPR-Cas9 基因敲除瘦素敲除小鼠中新型便秘表型的分子特征
Int J Mol Sci. 2020 Dec 12;21(24):9464. doi: 10.3390/ijms21249464.